Home

Lichefia De asemenea extincţie cdx2 tumor marker Armistiţiu Șampanie Vegetație

CDX2, CK7 and CK20 staining in distant metastases of | Download Table
CDX2, CK7 and CK20 staining in distant metastases of | Download Table

CDX2 as a marker for intestinal differentiation: Its utility and limitations
CDX2 as a marker for intestinal differentiation: Its utility and limitations

CDX2 Protein Expression in Colorectal Cancer and ItsCorrelation with Clinical and Pathological Characteristics, Prognosis, and Survival Rate of Patients | SpringerLink
CDX2 Protein Expression in Colorectal Cancer and ItsCorrelation with Clinical and Pathological Characteristics, Prognosis, and Survival Rate of Patients | SpringerLink

A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases - ScienceDirect
A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases - ScienceDirect

Cancers | Free Full-Text | Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site
Cancers | Free Full-Text | Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site

Distribution of CDX2 expression in patients with colorectal cancer and... | Download Scientific Diagram
Distribution of CDX2 expression in patients with colorectal cancer and... | Download Scientific Diagram

A panel of intestinal differentiation markers (CDX2, GPA33, and LI-cadherin) identifies gastric cancer patients with favourable prognosis | SpringerLink
A panel of intestinal differentiation markers (CDX2, GPA33, and LI-cadherin) identifies gastric cancer patients with favourable prognosis | SpringerLink

Anti-CDX2 Antibody [CDX2/1690] (A248111) | Antibodies.com
Anti-CDX2 Antibody [CDX2/1690] (A248111) | Antibodies.com

Prognostic value of low CDX2 expression in colorectal cancers with a high stromal content – a short report | SpringerLink
Prognostic value of low CDX2 expression in colorectal cancers with a high stromal content – a short report | SpringerLink

Prognostic impact of CDX2 in stage II colon cancer: results from two nationwide cohorts | British Journal of Cancer
Prognostic impact of CDX2 in stage II colon cancer: results from two nationwide cohorts | British Journal of Cancer

JCI Insight - LIN28B induces a differentiation program through CDX2 in colon cancer
JCI Insight - LIN28B induces a differentiation program through CDX2 in colon cancer

Frontiers | CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup
Frontiers | CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup

CDX2 controls genes involved in the metabolism of 5-fluorouracil and is associated with reduced efficacy of chemotherapy in colorectal cancer - ScienceDirect
CDX2 controls genes involved in the metabolism of 5-fluorouracil and is associated with reduced efficacy of chemotherapy in colorectal cancer - ScienceDirect

CDX2 is involved in microRNA‑associated inflammatory carcinogenesis in gastric cancer
CDX2 is involved in microRNA‑associated inflammatory carcinogenesis in gastric cancer

Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients
Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients

CDX2 Expression in Cutaneous Metastatic Carcinomas and Extramammary Paget's Disease | Anticancer Research
CDX2 Expression in Cutaneous Metastatic Carcinomas and Extramammary Paget's Disease | Anticancer Research

Impact of CDX2 expression status on the survival of patients after curative resection for colorectal cancer liver metastasis | BMC Cancer | Full Text
Impact of CDX2 expression status on the survival of patients after curative resection for colorectal cancer liver metastasis | BMC Cancer | Full Text

CDX2 Antibody (EP25) - Bio SB
CDX2 Antibody (EP25) - Bio SB

CDX2 marker as immunohistochemistry stain was positive as brown color... | Download Scientific Diagram
CDX2 marker as immunohistochemistry stain was positive as brown color... | Download Scientific Diagram

Combination of CDX2 expression and T stage improves prognostic prediction of colorectal cancer - Weimin Xu, Yilian Zhu, Wei Shen, Wenjun Ding, Tingyu Wu, Yuegui Guo, Xiaobing Chen, Mingxia Zhou, Yingwei Chen,
Combination of CDX2 expression and T stage improves prognostic prediction of colorectal cancer - Weimin Xu, Yilian Zhu, Wei Shen, Wenjun Ding, Tingyu Wu, Yuegui Guo, Xiaobing Chen, Mingxia Zhou, Yingwei Chen,

CDX2 Antibody - Biocare Medical
CDX2 Antibody - Biocare Medical

ARE CDX2, BETA-CATENIN AND WNT IMMUNOMARCHERS USEFUL FOR EVALUATING THE CHANCE OF DISEASE PROGRESSION OR EVOLUTION TO DEATH IN P
ARE CDX2, BETA-CATENIN AND WNT IMMUNOMARCHERS USEFUL FOR EVALUATING THE CHANCE OF DISEASE PROGRESSION OR EVOLUTION TO DEATH IN P

Cancers | Free Full-Text | Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site
Cancers | Free Full-Text | Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site

Mismatch repair phenotype determines the implications of tumor grade and CDX2 expression in stage II–III colon cancer - Modern Pathology
Mismatch repair phenotype determines the implications of tumor grade and CDX2 expression in stage II–III colon cancer - Modern Pathology

CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression | Cell Death & Disease
CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression | Cell Death & Disease